Aishwarya Kulkarni

1.1k citations
24 papers · 716 indexed · h-index 12
Topics
Hippo pathway signaling and YAP/TAZ (4 papers)Acute Myeloid Leukemia Research (3 papers)RNA Research and Splicing (3 papers)

In The Last Decade

Aishwarya Kulkarni

23 papers receiving 712 citations

Peers

Aishwarya Kulkarni
Comparison fields: 5 of 102
  • Molecular Biology 272
  • Immunology 258
  • Oncology 120
  • Hematology 109
  • Cell Biology 93
Replace Hai Hu with:
Hai Hu United States
Elizabeth S. Ng Australia
Rui Gao China
Thusanth Thuraisingam Canada
Liqiong Liu China
Qiang Feng China
Petra E. Bürgisser Netherlands
Qi Cai United States
Yoshihiro Yoshikawa Japan
Aishwarya Kulkarni relative to Hai Hu United States Hai Hu's profile →
Citations per field
00.5×1.5×2.4×
Hai Hu · 1×
Citations per year

Countries citing papers authored by Aishwarya Kulkarni

Since Specialization
Citations

This map shows the geographic impact of Aishwarya Kulkarni's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aishwarya Kulkarni with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aishwarya Kulkarni more than expected).

Fields of papers citing papers by Aishwarya Kulkarni

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aishwarya Kulkarni. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aishwarya Kulkarni. The network helps show where Aishwarya Kulkarni may publish in the future.

Co-authorship network of co-authors of Aishwarya Kulkarni

This figure shows the co-authorship network connecting the top 25 collaborators of Aishwarya Kulkarni. A scholar is included among the top collaborators of Aishwarya Kulkarni based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aishwarya Kulkarni. Aishwarya Kulkarni is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 5
2 2
3 1
4 29
5 6
6 61
7 2
8 3
9 35
10 50
11 12
12 2
13 155
14 21
15 2
16 9
17 38
18 45
19 28
20 184

About Aishwarya Kulkarni

Aishwarya Kulkarni is a scholar working on Cell Biology, Hematology and Industrial and Manufacturing Engineering, having authored 24 papers that have together received 716 indexed citations. Recurring topics across this work include Hippo pathway signaling and YAP/TAZ (4 papers), Acute Myeloid Leukemia Research (3 papers) and RNA Research and Splicing (3 papers). The work is most often cited by research in Immunology (258 citations), Hematology (109 citations) and Cell Biology (93 citations). Aishwarya Kulkarni has collaborated with scholars based in United States, India and Australia. Frequent co-authors include Kieran F. Harvey, Harshini Dasari, Joseph H.A. Vissers, Mark H. Kaplan, Rukhsana Jabeen, Evelyn Nguyen, Chang H. Kim, Elizabeth J. Taparowsky, Matthew R. Olson and Baohua Zhou. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and Journal of Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026